Revolutionary Digital Twins: The Future of Clinical Trials
In this interview with Gian Carlo (GC) Ochoa, a leading figure in digital twins technology for clinical trials, we...
Moe Alsumidaie
Cytonics CYT-108: A Unique Approach to OA Treatment
In this interview, we spoke with Joey Bose, President & CEO of Cytonics, diving into the intricacies of their...
FDA NIH & DARPA Government Agencies Lead New DCT Initiatives
In today’s discussion, we’re joined by Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance (DTRA), who shares...
Master Protocols: FDA New Flexible Approach in Cancer Trials
Master Protocols (MPs) mark a significant evolution in the realm of clinical research, especially notable in oncology. These protocols,...
A Great Divide: Sponsors Clash With FDA on Trial Data Excess
A new study, conducted collaboratively by the Tufts Center for the Study of Drug Development (Tufts CSDD), the FDA,...
Clinical Trial GCP Focus: Powerful QA Strategies Revealed
One of the most well-received presentations from Momentum Events’ December 2023 2nd GCP Inspection Readiness Conference was Tony Johnson,...
FDA Unveils Groundbreaking Rare Disease Guidance Document
In a landmark move, the U.S. Food and Drug Administration (FDA) has released a detailed guidance document titled “Rare...
AI in Action: Medidata Focuses on Data Entry, Diverse Trials
Dive into the forefront of clinical trial innovation with our interview featuring Anthony Costello from Medidata. We discuss groundbreaking...
Breaking New Ground: AstraZeneca, Roche, Acadia in GCP & AI
The 2nd GCP Inspection Readiness Conference, convened by Momentum Events, attracted a significant gathering of clinical experts in the...
uMotif Shaping New Patient-Centric Design in Clinical Trials
In today’s dialogue, we are privileged to converse with Bruce Hellman from uMotif, a company at the forefront of...